Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progression. Deiman FE, Arslan T, de Brouwer R, Henry I, et al. Cardiovasc Res 2026;122:1104-1118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Deiman FE, Arslan T, de Brouwer R, Henry I, et al. Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progression. Cardiovasc Res 2026;122:1104-1118.
PMID: 42033765